EUVIMEDEUVIMED entdecken
Crossref

Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice

Piaojian Yu, Wei Wang, Wanrong Guo, Lidan Cheng, Zhiping Wan, Yanglei Cheng, Yunfeng Shen, Fen Xu

Experimental and Clinical Endocrinology & Diabetes · 2023-11 · 131 (11) · 595-604

DOI: 10.1055/a-2178-9113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 03.11.2023. Verfasst von Piaojian Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Adipose Tissue, Brown, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Local Innovative and Research Teams Projects of Guangdong Pearl River Talents Program, National Natural Science Foundation of China Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pioglitazone is an insulin sensitizer used for the treatment of type 2 diabetes mellitus (T2DM) by activating peroxisome proliferator-activated receptor gamma. This study aimed to investigate the effects of pioglitazone on white adipose tissue (WAT) and brown adipose tissue (BAT) in diet-induced obese (DIO) mice.

Methods

C57BL/6 mice were treated with pioglitazone (30 mg/kg/day) for 4 weeks after a 16-week high-fat diet (HFD) challenge. Body weight gain, body fat mass, energy intake, and glucose homeostasis were measured during or after the treatment. Histopathology was observed by hematoxylin and eosin, oil red O, immunohistochemistry, and immunofluorescence staining. Expression of thermogenic and mitochondrial biogenesis-related genes was detected by quantitative real-time PCR and western blotting.

Results

After 4-week pioglitazone treatment, the fasting blood glucose levels, glucose tolerance, and insulin sensitivity were significantly improved, but the body weight gain and fat mass were increased in DIO mice. Compared with the HFD group, pioglitazone did not significantly affect the weights of liver and WAT in both subcutaneous and epididymal regions. Unexpectedly, the weight of BAT was increased after pioglitazone treatment. Histological staining revealed that pioglitazone ameliorated hepatic steatosis, reduced the adipocyte size in WAT, but increased the adipocyte size in BAT.

Conclusion

Though pioglitazone can promote lipolysis, thermogenesis, and mitochondrial function in WAT, it leads to impaired thermogenesis, and mitochondrial dysfunction in BAT. In conclusion, pioglitazone could promote the browning of WAT but led to the whitening of BAT; the latter might be a new potential mechanism of pioglitazone-induced weight gain during T2DM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose Tissue, BrownDiabetes Mellitus, Type 2MiceAnimalsPioglitazoneObesityMice, ObeseMice, Inbred C57BLWeight GainAdipose Tissue, WhiteDiet, High-FatGlucose

Substanzen

PioglitazoneGlucose

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, Guangdong Province, China.
  • Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-sen University.
  • Department of Endocrinology and Metabolism, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
  • Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
  • Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Förderung

  • Guangzhou Municipal Science and Technology Project
  • Local Innovative and Research Teams Projects of Guangdong Pearl River Talents Program
  • National Natural Science Foundation of China Grant

Zitieren

APA

Yu, P., Wang, W., Guo, W., Cheng, L., Wan, Z., Cheng, Y., Shen, Y., & Xu, F. (2023). Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice. Experimental and Clinical Endocrinology & Diabetes, 131(11), 595-604. https://doi.org/10.1055/a-2178-9113

Vancouver

Yu P, Wang W, Guo W, Cheng L, Wan Z, Cheng Y, et al. Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice. Experimental and Clinical Endocrinology & Diabetes. 2023;131(11):595-604. doi:10.1055/a-2178-9113

BibTeX
@article{Yu2023,
  author = {Yu, Piaojian and Wang, Wei and Guo, Wanrong and Cheng, Lidan and Wan, Zhiping and Cheng, Yanglei and Shen, Yunfeng and Xu, Fen},
  title = {Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2023},
  volume = {131},
  number = {11},
  pages = {595--604},
  doi = {10.1055/a-2178-9113}
}
Kostenlos starten →